1. Home
  2. KODK vs DBVT Comparison

KODK vs DBVT Comparison

Compare KODK & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$8.39

Market Cap

934.0M

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$15.67

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
DBVT
Founded
1880
2002
Country
United States
France
Employees
N/A
90
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
934.0M
948.8M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
KODK
DBVT
Price
$8.39
$15.67
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$32.04
AVG Volume (30 Days)
876.7K
302.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
$4,114,000,000.00
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
N/A
$2,360.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.77
52 Week Low
$4.94
$8.51
52 Week High
$14.87
$26.19

Technical Indicators

Market Signals
Indicator
KODK
DBVT
Relative Strength Index (RSI) 32.26 40.22
Support Level $8.01 $12.63
Resistance Level $9.01 $17.78
Average True Range (ATR) 0.46 1.09
MACD -0.02 0.07
Stochastic Oscillator 7.86 17.79

Price Performance

Historical Comparison
KODK
DBVT

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: